Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H30O2 |
Molecular Weight | 290.4403 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]3([H])[C@@]2([H])CC[C@]4([H])C[C@H](O)CC[C@]34C
InChI
InChIKey=QGXBDMJGAMFCBF-BNSUEQOYSA-N
InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-16,20H,3-11H2,1-2H3/t12-,13-,14+,15+,16+,18+,19+/m1/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/15946323Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/5480865 |
https://www.ncbi.nlm.nih.gov/pubmed/16695933 |
https://www.ncbi.nlm.nih.gov/pubmed/17341652
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15946323
Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/5480865 |
https://www.ncbi.nlm.nih.gov/pubmed/16695933 |
https://www.ncbi.nlm.nih.gov/pubmed/17341652
Etiocholanone is an androstane neurosteroid. Etiocholanone potentiates GABA-A receptor currents and exerts anticolvunsant properties in rodents. Etiocholanolone demostrates pyrogenic properties.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15946323
Curator's Comment: Etiocholanolone have anticonvulsant properties in rodent models of epilepsy. No human data available.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Gas chromatography/combustion/isotope ratio mass spectrometry to control the misuse of androgens in breeding animals: new derivatisation method applied to testosterone metabolites and precursors in urine samples. | 2001 |
|
Diethylstilbestrol regulates trophoblast stem cell differentiation as a ligand of orphan nuclear receptor ERR beta. | 2001 Apr 1 |
|
Changes in androgenic steroid profile due to urine contamination by microorganisms: a prospective study in the context of doping control. | 2001 Feb 15 |
|
Putative steroidal pheromones in the round goby, Neogobius melanostomus: olfactory and behavioral responses. | 2001 Mar |
|
Pharmacological profile of the novel inotropic agent (E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride (PST2744). | 2002 Nov |
|
Urinary steroids in men with male-pattern alopecia. | 2002 Oct-Nov |
|
Diverse toxicity associated with cardiac Na+/K+ pump inhibition: evaluation of electrophysiological mechanisms. | 2003 May |
|
Studies on the radioprotective effect of etiocholanolone. | 2004 |
|
Urinary steroid metabolites and 11beta-hydroxysteroid dehydrogenase activity in patients with unipolar recurrent major depression. | 2004 Jul |
|
Production rates of cortisol in obesity. | 2004 Sep |
|
Urinary steroid excretion rates in acromegaly. | 2005 |
|
Modulation of sarcoplasmic reticulum function by Na+/K+ pump inhibitors with different toxicity: digoxin and PST2744 [(E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride]. | 2005 Apr |
|
Isotopic fractionation of endogenous anabolic androgenic steroids and its relationship to doping control in sports. | 2005 Jan |
|
In vitro biosynthesis of novel 5beta-reduced steroids by the testis of the round goby, Neogobius melanostomus. | 2005 Jan 1 |
|
Steroids and thermogenesis. | 2006 |
|
Application of stable carbon isotope analysis to the detection of testosterone administration to cattle. | 2006 Apr 19 |
|
Emerging therapies for the management of decompensated heart failure: from bench to bedside. | 2006 Dec 19 |
|
Determination of the origin of urinary norandrosterone traces by gas chromatography combustion isotope ratio mass spectrometry. | 2006 Sep |
|
Targeting SERCA2a as an innovative approach to the therapy of congestive heart failure. | 2007 |
|
Variations in urine excretion of steroid hormones after an acute session and after a 4-week programme of strength training. | 2007 Jan |
|
A phase 1-2 dose-escalating study evaluating the safety and tolerability of istaroxime and specific effects on electrocardiographic and hemodynamic parameters in patients with chronic heart failure with reduced systolic function. | 2007 Jan 22 |
|
Istaroxime: an investigational luso-inotropic agent for acute heart failure syndromes. | 2007 Jan 22 |
|
The neuro-steroid, 3beta androstene 17alpha diol exhibits potent cytotoxic effects on human malignant glioma and lymphoma cells through different programmed cell death pathways. | 2007 Sep 3 |
|
Overview of emerging pharmacologic agents for acute heart failure syndromes. | 2008 Feb |
|
Neurosteroid analogues. 12. Potent enhancement of GABA-mediated chloride currents at GABAA receptors by ent-androgens. | 2008 Jan |
|
Short term impact of Tribulus terrestris intake on doping control analysis of endogenous steroids. | 2008 Jun 10 |
|
Direct quantification of steroid glucuronides in human urine by liquid chromatography-electrospray tandem mass spectrometry. | 2008 Mar 7 |
|
The effects of sex, age and commensal way of life on levels of fecal glucocorticoid metabolites in spiny mice (Acomys cahirinus). | 2008 Sep 3 |
|
The urinary steroid profile in patients diagnosed with adrenal incidentaloma. | 2009 Apr |
|
Detection of testosterone administration based on the carbon isotope ratio profiling of endogenous steroids: international reference populations of professional soccer players. | 2009 Dec |
|
Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition: a new promising treatment for acute heart failure syndromes? | 2009 Dec |
|
Dietary enterolactone affects androgen and estrogen levels in healthy postmenopausal women. | 2009 Feb |
|
Physiological concentrations of anabolic steroids in human hair. | 2009 Jan 30 |
|
Determination of the deuterium/hydrogen ratio of endogenous urinary steroids for doping control purposes. | 2009 Jul |
|
Drug testing data from the 2007 Pan American Games: delta13C values of urinary androsterone, etiocholanolone and androstanediols determined by GC/C/IRMS. | 2009 Jul |
|
Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trial. | 2009 Jun |
|
Isotope ratio mass spectrometry analysis of the oxidation products of the main and minor metabolites of hydrocortisone and cortisone for antidoping controls. | 2009 Mar |
|
Urinary and serum hormones profiles after testosterone enanthate administration in male hypogonadism: concerns on the detection of doping with testosterone in treated hypogonadal athletes. | 2009 May |
|
The effects of DHEA, 3beta-hydroxy-5alpha-androstane-6,17-dione, and 7-amino-DHEA analogues on short term and long term memory in the mouse. | 2009 Nov |
Sample Use Guides
After increasing diastolic blood pressure (DBP) in rats by a continuous infusion of norepinephrine (0.059 uM/kg/min), intravenous bolus injections of etiocholanolone (5-25 uM/kg) produced dose-dependent vasodepressor responses.
Etiocholanolone (intraperitoneal injection) have anticonvulsant properties in rodent models of epilepsy: it was active in the 6-Hz and pentylenetetrazol models (ED50 values, 76.9 and 139 mg/kg, respectively),
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12475725
10-100 uM etiocholanolone in a dose- and time-dependent manner has an anti-proliferative action on human cancer cell lines.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
82850-9
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
||
|
NCI_THESAURUS |
C2139
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
||
|
LOINC |
34301-2
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
||
|
LOINC |
34303-8
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
||
|
LOINC |
15065-6
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
||
|
LOINC |
2266-5
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
||
|
NCI_THESAURUS |
C2298
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
||
|
LOINC |
30508-6
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
||
|
LOINC |
82847-5
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
||
|
LOINC |
82851-7
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
||
|
CFR |
21 CFR 862.1285
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
||
|
LOINC |
56488-0
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
||
|
LOINC |
82846-7
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
||
|
LOINC |
13614-3
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
||
|
LOINC |
82881-4
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
||
|
LOINC |
82852-5
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
||
|
LOINC |
2268-1
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
||
|
LOINC |
44355-6
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
||
|
LOINC |
82882-2
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
||
|
LOINC |
2267-3
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
||
|
LOINC |
34302-0
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
||
|
LOINC |
80157-1
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
||
|
LOINC |
82853-3
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
50908
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
PRIMARY | |||
|
DTXSID001018919
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
PRIMARY | |||
|
C29023
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
PRIMARY | |||
|
28195
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
PRIMARY | |||
|
D005043
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
PRIMARY | |||
|
ETIOCHOLANOLONE
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
PRIMARY | |||
|
5880
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
PRIMARY | |||
|
DB02854
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
PRIMARY | |||
|
53-42-9
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
PRIMARY | |||
|
97CGB1M48I
Created by
admin on Fri Dec 15 16:18:34 GMT 2023 , Edited by admin on Fri Dec 15 16:18:34 GMT 2023
|
PRIMARY |
METABOLITE (PARENT)
PARENT (METABOLITE TOXIC)
PARENT (METABOLITE)
SUBSTANCE RECORD